{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:55:09Z","timestamp":1792068909002,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bmc.2026.118791","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:18:37Z","timestamp":1788362317000},"page":"118791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis and evaluation of fluorinated CYP1B1 inhibitors based on a trans-stilbene scaffold"],"prefix":"10.1016","volume":"143","author":[{"given":"Meixian","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dachuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118791_bb0005","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/nrc2015","article-title":"The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis","volume":"6","author":"Nebert","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2026.118791_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/cells13231958","article-title":"Human cytochrome P450 cancer-related metabolic activities and gene polymorphisms: a review","volume":"13","author":"Mokhosoev","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2026.118791_bb0015","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2174\/1871520623666230119103914","article-title":"CYP1B1: a promising target in Cancer drug discovery","volume":"23","author":"Fabris","year":"2023","journal-title":"Anti Cancer Agents Med Chem"},{"key":"10.1016\/j.bmc.2026.118791_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100045","article-title":"Heme-thiolate monooxygenase cytochrome P450 1B1, an old dog with many new tricks","volume":"77","author":"Kim","year":"2025","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bmc.2026.118791_bb0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejmech.2018.11.039","article-title":"Phytoestrogens and their synthetic analogues as substrate mimic inhibitors of CYP1B1","volume":"163","author":"Mohd Siddique","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118791_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111938","article-title":"Synthesis and structure-activity relationship studies of \u03b1-naphthoflavone derivatives as CYP1B1 inhibitors","volume":"187","author":"Dong","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118791_bb0035","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/cmdc.201600316","article-title":"Flavonoids and Naphthoflavonoids: wider roles in the modulation of cytochrome P450 family\u00a01 enzymes","volume":"11","author":"Dong","year":"2016","journal-title":"Chem Med Chem"},{"key":"10.1016\/j.bmc.2026.118791_bb0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/carcin\/bgp252","article-title":"Basic properties and molecular mechanisms of exogenous chemical carcinogens","volume":"31","author":"Irigaray","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bmc.2026.118791_bb0045","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1021\/acs.jmedchem.4c00164","article-title":"Design of Novel 2-Phenylquinazolin-4-amines as selective CYP1B1 inhibitors for overcoming paclitaxel resistance in A549 cells","volume":"67","author":"Yang","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118791_bb0050","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3892\/ijmm.2014.2041","article-title":"CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro","volume":"35","author":"Zhu","year":"2015","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.bmc.2026.118791_bb0055","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1016\/j.bmcl.2017.11.013","article-title":"Glycyrrhiza glabra extract and quercetin reverses cisplatin resistance in triple-negative MDA-MB-468 breast cancer cells via inhibition of cytochrome P450 1B1 enzyme","volume":"27","author":"Sharma","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118791_bb0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1039\/C6MD00394J","article-title":"Adaptive mechanisms of resistance to anti-neoplastic agents","volume":"8","author":"Ferreira","year":"2017","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bmc.2026.118791_bb0065","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1021\/tx980090+","article-title":"Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1","volume":"11","author":"Shimada","year":"1998","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.bmc.2026.118791_bb0070","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1021\/jf0116855","article-title":"Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol","volume":"50","author":"Rimando","year":"2002","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.bmc.2026.118791_bb0075","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.taap.2013.07.005","article-title":"Inhibition of CYP1 by berberine, palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling","volume":"272","author":"Lo","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bmc.2026.118791_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118385","article-title":"Phytoestrogens and their synthetic analogues as substrate mimic inhibitors of CYP1B1 - an update (2020-2025)","volume":"130","author":"Biswas","year":"2025","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118791_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129533","article-title":"Design, synthesis, and evaluation of (18)F-labeling CYP1B1 PET tracer based on 2-Phenylquinazolin","volume":"96","author":"Cai","year":"2023","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118791_bb0090","doi-asserted-by":"crossref","first-page":"8238","DOI":"10.3390\/ijms22158238","article-title":"The 3,4-Quinones of Estrone and estradiol are the initiators of Cancer whereas resveratrol and N-acetylcysteine are the preventers","volume":"22","author":"Cavalieri","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118791_bb0095","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.semcancer.2015.11.001","article-title":"Resveratrol for breast cancer prevention and therapy: preclinical evidence and molecular mechanisms","volume":"40","author":"Sinha","year":"2016","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.bmc.2026.118791_bb0100","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/jm010298j","article-title":"Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors","volume":"45","author":"Kim","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118791_bb0105","doi-asserted-by":"crossref","first-page":"16451","DOI":"10.1021\/acs.jmedchem.2c01306","article-title":"Structure-based drug design and synthesis of novel N-Aryl-2,4-bithiazole-2-amine CYP1B1-selective inhibitors in overcoming Taxol resistance in A549 cells","volume":"65","author":"Mao","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118791_bb0110","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/179663a0","article-title":"Fluorinated pyrimidines, a new class of tumour-inhibitory compounds","volume":"179","author":"Heidelberger","year":"1957","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2026.118791_bb0115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.pharmtox.41.1.443","article-title":"Metabolism of fluorine-containing drugs","volume":"41","author":"Park","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bmc.2026.118791_bb0120","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","article-title":"Applications of fluorine in medicinal chemistry","volume":"58","author":"Gillis","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118791_bb0125","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1126\/science.1131943","article-title":"Fluorine in pharmaceuticals: looking beyond intuition","volume":"317","author":"M\u00fcller","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.bmc.2026.118791_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116722","article-title":"Synthetic approaches and application of representative clinically approved fluorine-enriched anti-cancer medications","volume":"276","author":"Liu","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118791_bb0135","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.bcp.2010.01.028","article-title":"Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes","volume":"79","author":"Yamaori","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2026.118791_bb0140","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3390\/ijms26031002","article-title":"Molecular docking study and 3D-QSAR model for trans-stilbene derivatives as ligands of CYP1B1","volume":"26","author":"Dutkiewicz","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118791_bb0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.annonc.2020.10.479","article-title":"Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial","volume":"32","author":"Shi","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bmc.2026.118791_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116670","article-title":"Ferroptosis-inducing compounds synergize with docetaxel to overcome chemoresistance in docetaxel-resistant non-small cell lung cancer cells","volume":"276","author":"Huang","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118791_bb0155","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.2174\/0929867326666191016113631","article-title":"Recent advances in elucidating paclitaxel resistance mechanisms in non-small cell lung Cancer and strategies to overcome drug resistance","volume":"27","author":"Cui","year":"2020","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2026.118791_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118000","article-title":"Trans-Styrylquinazolinone CYP1B1 inhibitors as potential therapeutics in A549 cells","volume":"298","author":"Cai","year":"2025","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118791_bb0165","doi-asserted-by":"crossref","first-page":"13089","DOI":"10.1021\/acs.jmedchem.5c01181","article-title":"Discovery of highly selective CYP1B1 inhibitors","volume":"68","author":"Wang","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118791_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108838","article-title":"Discovery of novel selective CYP1B1 inhibitors: design, synthesis and biological evaluation","volume":"164","author":"Li","year":"2025","journal-title":"Bioorg Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:36:45Z","timestamp":1792067805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626002476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":34,"alternative-id":["S0968089626002476"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118791","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and evaluation of fluorinated CYP1B1 inhibitors based on a trans-stilbene scaffold","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118791"}}